Overview

Reduced-dose Botox for Urgency Incontinence Among Elder Females: A Mixed-methods Randomized Controlled Trial

Status:
Not yet recruiting

Trial end date:
2027-01-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to study the treatment of urgency urinary incontinence (UUI), specifically among women 70 years and older, by comparing low-and standard dose of onabotulinumtoxinA (BTX; trade name BOTOX(c)) injection in the bladder.

Phase:

Phase 1/Phase 2

Details

Lead Sponsor:

Dartmouth-Hitchcock Medical Center

Collaborators:

Dartmouth College
Kaiser Permanente
Oregon Health and Science University
Patient-Centered Outcomes Research Institute
Stanford University
University of Alabama at Birmingham
University of Connecticut
University of Pittsburgh
University of Texas

Treatments:

abobotulinumtoxinA
Botulinum Toxins, Type A